21st.BIO Competitors and Similar CompaniesClear all
Centogene's competitors and similar companies include CN Bio.
 Centogene Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases. |  CN Bio CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research. | |
Founding Date | Founding Date 2005 | Founding Date 2008 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Rostock, DE HQ Wien, AT Berlin, DE Frankfurt Am Main, DE Hamburg, DE Greater Noida, IN Dubai, AE see more | Locations Milton, GB HQ |
Employees | Employees 80823% increase | Employees 576% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €48.5m (FY, 2023) | Revenue (est.) £3.5m (FY, 2024) |
Cost of goods | Cost of goods €29.1m (FY, 2023) | Cost of goods £1.4m (FY, 2024) |
Gross profit | Gross profit €23.7m (FY, 2023) | Gross profit £2.1m (FY, 2024) |
Net income | Net income (€35.5m) (FY, 2023) | Net income (£6.3m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 29.6m | Total funding raised $ 11.5m |
For sources of this data, please see the company profile
View Company Profiles
CN Bio
HQ
Milton, GB
CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research.
View company